Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids

Cardiovascular Research

Volumn 34, Issue 3, 1997, Pages 590-596

  Lewis, Tamara V ^a   Dart, Anthony M ^a   Chin Dusting, Jaye P F ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Aorta; Human, lipoproteins; Nitric oxide; Phospholipids; Rat; Vascular reactivity

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BOVINE SERUM ALBUMIN; CALCIMYCIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HISTAMINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITROPRUSSIDE SODIUM; PHOSPHOLIPID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CALCIMYCIN; ENDOTHELIUM, VASCULAR; HISTAMINE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 0030905327     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00061-8     Document Type: Article

References (25)

1. Zeiher A. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83:1991;391-401.
2. Cohen R.A., Zitnay K.M., Haudenschild C.C., Cunningham L.D. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res. 63:1988;903-910.
3. Chowiencyzk P.J., Watts G.F., Cockcroft J.R., Ritter J.M. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1992;1430-1432.
4. Chin J.P.F., Dart A.M. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils. Clin Exp Pharmacol Physiol. 21:1994;749-755.
5. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
6. Plane F., Bruckdorfer K.R., Kerr P., Steuer A., Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 105:1992;216-222.
7. Plane F., Kerr P., Bruckdorfer K.R., Jacobs M. Inhibition of endothelium-dependent relaxation by oxidized LDLs. Biochem Soc Trans. 18:1990;1177-1178.
8. Takahashi I.M., Yui Y., Yasomoto H., Morishita H., Hattori R., Kawai C. Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol. 258:1990;H1-H8.
9. Chin J.H., Azhar S., Hoffman B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 89:1992;10-18.
10. Schmid K., Klatt P., Graier W.F., Kostner G.M., Kukovetz W.R. High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylylate cyclase. Biochem Biophys Res Commun. 182:1992;302-308.
11. Yokohoma M., Hirata K., Miyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidised low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301-308.
12. Peterson G.L. A simplification of the protein assay method of Lowry et al., which is more generally applicable. Anal Biochem. 83:1977;346-356.
13. Abbey M., Nestel P.J., Baghurst P.A. Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr. 58:1992;525-532.
14. Nakashima A., Angus J.A., Johnston C.I. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea-pig atria. Eur J Pharmacol. 81:1982;487-492.
15. Kuhn F.E., Mohler E.R., Satler L.F., Reagan K., Lu D.Y., Rackley C.E. Effects of high-density lipoprotein on ACh-induced coronary vasoreactivity. Am J Cardiol. 68:1991;1425-1430.
16. Miyazaki A., Rahim A.T.A., Morino O.Y., Horiuchi S. HDL mediates selective reduction in cholesterol esters from macrophages foam cells. Biochim Biophys Acta. 1126:1992;73-80.
17. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta. 1044:1990;275-283.
18. Cooke J.P., Andon N.A., Girerd X.J., Hirsch A.T., Creager M.A. Arginine restores cholinergic relaxation of hypercholesterolaemic rabbit thoracic aorta. Circulation. 83:1991;1057-1062.
19. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzau V.J., Cooke J.P. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolaemic humans. J Clin Invest. 90:1992;1248-1253.
20. Jeserich M., Munzel T., Just H., Drexler H. Reduced plasma L-arginine in hypercholesterolaemia. Lancet. 339:1992;561.
21. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized LDLs on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 11:1991;198-203.
22. White C.R., Brock T.A., Chang L.Y.et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91(Feb):1994;1044-1048.
23. i proteins by LDL attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J Biol Chem. 269:1994;12987-12992.
24. Flavahan N.A. Atherosclerosis or lipoprotein induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 85(5):1992;1927-1938.
25. Yuan Y., Granger H.J., Zawieja D.C., Defily D.V., Chilian W.M. Histamine increases venular permeability via a phospholipase C-NO synthase guanylate cyclase cascade. Am J Physiol. 264:1993;H1734-H1739.